These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9437571)

  • 1. Maintenance electroconvulsive therapy for Parkinson's disease.
    Aarsland D; Larsen JP; Waage O; Langeveld JH
    Convuls Ther; 1997 Dec; 13(4):274-7. PubMed ID: 9437571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.
    Pintor LP; Valldeoriola F; Fernández-Egea E; Sánchez R; Rami L; Tolosa E; Muñiz A; Martí MJ; Bernardo M
    J ECT; 2012 Jun; 28(2):87-91. PubMed ID: 22531200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroconvulsive therapy in Parkinson disease. Description of three cases].
    Avila A; Sastre F; Cardona X; Maho P; Bello J; Sancho I
    Neurologia; 1997; 12(7):313-6. PubMed ID: 9432202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor Function Improvement After Electroconvulsive Therapy in a Parkinson's Disease Patient With Deep Brain Stimulator.
    Volkaerts L; Roels R; Bouckaert F
    J ECT; 2020 Mar; 36(1):66-68. PubMed ID: 31652177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECT and Parkinson's disease revisited: a "naturalistic" study.
    Douyon R; Serby M; Klutchko B; Rotrosen J
    Am J Psychiatry; 1989 Nov; 146(11):1451-5. PubMed ID: 2817117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance ECT in Parkinson's disease.
    Fall PA; Granérus AK
    J Neural Transm (Vienna); 1999; 106(7-8):737-41. PubMed ID: 10907732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena.
    Andersen K; Balldin J; Gottfries CG; Granérus AK; Modigh K; Svennerholm L; Wallin A
    Acta Neurol Scand; 1987 Sep; 76(3):191-9. PubMed ID: 2446463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome.
    Ward C; Stern GM; Pratt RT; McKenna P
    J Neural Transm; 1980; 49(1-2):133-5. PubMed ID: 7441236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.
    Williams NR; Bentzley BS; Sahlem GL; Pannu J; Korte JE; Revuelta G; Short EB; George MS
    Acta Neurol Scand; 2017 Apr; 135(4):407-411. PubMed ID: 27241213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients.
    Valldeoriola F; Pilleri M; Tolosa E; Molinuevo JL; Rumià J; Ferrer E
    Mov Disord; 2002 Jan; 17(1):125-32. PubMed ID: 11835449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa.
    Rampello L; Chiechio S; Raffaele R; Vecchio I; Nicoletti F
    Clin Neuropharmacol; 2002; 25(1):21-4. PubMed ID: 11852292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Takamiya A; Seki M; Kudo S; Yoshizaki T; Nakahara J; Mimura M; Kishimoto T
    Mov Disord; 2021 Jan; 36(1):50-58. PubMed ID: 33280168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance electroconvulsive therapy for intractable Parkinson's disease.
    Wengel SP; Burke WJ; Pfeiffer RF; Roccaforte WH; Paige SR
    Am J Geriatr Psychiatry; 1998; 6(3):263-9. PubMed ID: 9659959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of electroconvulsive therapy in Parkinson's disease: A clinical trial.
    Afshari D; Shakeri J; Khodamoradi M; Abadi RNS; Rahkan J; Afshar Hezarkhani L
    Neurosci Lett; 2022 Feb; 772():136449. PubMed ID: 35026333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation and maintenance ECT: a review of recent research.
    Andrade C; Kurinji S
    J ECT; 2002 Sep; 18(3):149-58. PubMed ID: 12394534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Parkinson's disease with electroconvulsive therapy.
    Rasmussen K; Abrams R
    Psychiatr Clin North Am; 1991 Dec; 14(4):925-33. PubMed ID: 1771154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinson's disease].
    Miyoshi K
    Nihon Rinsho; 2001 Aug; 59(8):1570-3. PubMed ID: 11519161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.